Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: Technical feasibility and assessment of lesion conspicuity in DWI

Journal of Magnetic Resonance Imaging

Volumn 33, Issue 5, 2011, Pages 1160-1170

  Eiber, Matthias ^a   Holzapfel, Konstantin ^a   Ganter, Carl ^a   Epple, Kathrin ^a   Metz, Stephan ^a   Geinitz, Hans ^b   Kübler, Hubert ^b   Gaa, Jochen ^a   Rummeny, Ernst J ^a   Beer, Ambros J ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

image quality; lesion conspicuity; prostate cancer; technical feasibility; whole body DWI

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE QUALITY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; WHOLE BODY MRI;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; WHOLE BODY IMAGING;

EID: 79955435842     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22542     Document Type: Article

References (40)

1. Krause B, Souvatzoglou M, Tuncel M, et al. The detection rate of [(11)C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2008; 35: 18-23. (Pubitemid 350234152)
2. Tuncel M, Souvatzoglou M, Herrmann K, et al. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer. Nucl Med Biol 2008; 35: 689-695.
3. Lauenstein T, Goehde S, Herborn C, et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology 2004; 233: 139-148. (Pubitemid 39280968)
4. Schlemmer H, Schäfer J, Pfannenberg C, et al. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 2005; 40: 64-71. (Pubitemid 40144410)
5. Schmidt GP, Baur-Melnyk A, Haug A, et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol 2008; 65: 47-58.
6. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M,. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22: 275-282. (Pubitemid 39264807)
7. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008; 248: 643-654.
8. Takenaka D, Ohno Y, Matsumoto K, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 2009; 30: 298-308.
9. Nakanishi K, Kobayashi M, Nakaguchi K, et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 2007; 6: 147-155.
10. Eiber M, Beer AJ, Holzapfel K, et al. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 2010; 45: 15-23.
11. Beer AJ, Eiber M, Souvatzoglou M, et al. Restricted Water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol Imaging Biol 2010 [Epub ahead of print].
12. Luboldt W, Kufer R, Blumstein N, et al. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 2008; 249: 1017-1025.
13. Kiliçkesmez O, Yirik G, Bayramoglu S, Cimilli T, Aydin S,. Non-breath-hold high b-value diffusion-weighted MRI with parallel imaging technique: apparent diffusion coefficient determination in normal abdominal organs. Diagn Intervent Radiol (Ankara, Turkey) 2008; 14: 83-87. (Pubitemid 352002996)
14. Taouli B, Sandberg A, Stemmer A, et al. Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging 2009; 30: 561-568.
15. Yoshikawa T, Kawamitsu H, Mitchell DG, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 2006; 187: 1521-1530. (Pubitemid 44788683)
16. Kwee TC, Takahara T, Ochiai R, et al. Whole-body diffusion-weighted magnetic resonance imaging. Eur J Radiol 2009; 70: 409-417.
17. Kwee TC, Quarles van Ufford HME, Beek FJ, et al. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 2009; 44: 683-690.
18. Murtz P, Krautmacher C, Traber F, Gieseke J, Schild H, Willinek W,. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007; 17: 3031-3037. (Pubitemid 350142327)
19. Bruegel M, Gaa J, Waldt S, et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol 2008; 191: 1421-1429.
20. Holzapfel K, Bruegel M, Eiber M, et al. Characterization of small (
21. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (New York) 2009; 11: 102-125.
22. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H,. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210: 617-623. (Pubitemid 29124018)
23. Müller MF, Prasad P, Siewert B, Nissenbaum MA, Raptopoulos V, Edelman RR,. Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994; 190: 475-478. (Pubitemid 24044255)
24. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T,. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 1999; 24: 456-461. (Pubitemid 29411497)
25. Oner AY, Aggunlu L, Akpek S, Tali T, Celik A,. Diffusion-weighted imaging of the appendicular skeleton with a non-Carr-Purcell-Meiboom-Gill single-shot fast spin-echo sequence. AJR Am J Roentgenol 2007; 189: 1494-1501. (Pubitemid 350174821)
26. Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JH,. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Intervent Radiol 2007; 18: 957-963. (Pubitemid 47126311)
27. Yuan Z, Ye X, Dong S, et al. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma. Eur J Radiol 2009; 75: e9-14.
28. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H,. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999; 173: 393-398. (Pubitemid 29347365)
29. Vilanova J, Barcelo J,. Diffusion-weighted whole-body MR screening. Eur J Radiol 2008; 67: 440-447.
30. Müller D, Bauer J, Zeile M, Rummeny E, Link T,. Significance of sagittal reformations in routine thoracic and abdominal multislice CT studies for detecting osteoporotic fractures and other spine abnormalities. Eur Radiol 2008; 18: 1696-1702.
31. Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A,. Fat suppression in MR imaging: techniques and pitfalls. Radiographics 1999; 19: 373-382.
32. Koh D, Takahara T, Imai Y, Collins DJ,. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci 2007; 6: 211-224.
33. Hackländer T, Scharwächter C, Golz R, Mertens H,. [Value of diffusion-weighted imaging for diagnosing vertebral metastases due to prostate cancer in comparison to other primary tumors.] Rofo 2006; 178: 416-424.
34. Gutzeit A, Doert A, Froehlich J, et al. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 2010; 39: 333-343.
35. Mir N, Sohaib SA, Collins D, Koh DM,. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J Med Imaging Radiat Oncol 2010; 54: 358-364.
36. Lecouvet F, Geukens D, Stainier A, et al. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. J Clin Oncol 2007; 25: 3281-3287. (Pubitemid 47325613)
37. Ghanem N, Uhl M, Brink I, et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 2005; 55: 41-55. (Pubitemid 40798487)
38. Heesakkers R, Hovels A, Jager G, et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 2008; 9: 850-856.
39. Eschmann S, Pfannenberg A, Rieger A, et al. Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer. Nuklearmedizin 2007; 46: 161-168. (Pubitemid 47612279)
40. Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J,. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009; 72: 381-387.